Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-014988

Senior Vice President and CFO sold 7,500 shares at $8.81 ($66,075)

  • Senior Vice President and CFO acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

STAAB THOMAS R II · Senior Vice President and CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-04-04 Exercise or conversion : show line 1 in the form +7,500 $5.51 $41,325 140,176 D
2019-04-04 Sale : show line 2 in the form −7,500 $8.81 $66,075 132,676 D
Open-market sales · 7,500 sh · avg $8.81 · $66,075

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-04-04 Exercise or conversion : show line 3 in the form Emp. Stock Option (Right to Buy) −7,500 167,500 D
Loading xslF345X03/form4.xml…